Literature DB >> 8735874

Characteristics of histamine release from cultured human mast cells.

Y Igarashi1, M Kurosawa, O Ishikawa, Y Miyachi, H Saito, M Ebisawa, Y Iikura, M Yanagida, H Uzumaki, T Nakahata.   

Abstract

BACKGROUND: The mast cell is one of the important cells in the pathogenesis of allergic disorders. However, isolating human mast cells is a laborious procedure. Recently, cultured human mast cells raised from umbilical cord blood cells have become available. It is necessary to examine whether these cells are useful in investigating the role of mast cells in human diseases.
OBJECTIVE: The phenotype of mast cells depends on their anatomical sites. To examine which phenotype of mast cells these cultured mast cells most closely resemble, their ability to release was investigated.
METHODS: The mast cells were raised from human umbilical cord blood cells in the presence of stem cell factor and interleukin-6. To determine the mast cell subtypes, the mast cells were immunocytochemically stained for tryptase and chymase. The cultured mast cells were then stimulated with various secretagogues, and histamine release was measured by a fluorometric technique using high-performance liquid chromatography.
RESULTS: The immunocytochemical staining for mast cell proteases revealed that virtually all cells contained tryptase, the definitive marker of mast cells, and that about a quarter of the cells contained chymase. Anti-IgE effectively stimulated these mast cells to release histamine in a dose-dependent, time-dependent manner. The release was completed in about 30 min. One of the non-specific stimuli, calcium ionophore A23187, also induced histamine release in a dose-dependent, time-dependent manner. In contrast, compound 48/80 and substance P failed to induce histamine release from these cells.
CONCLUSION: Cultured human mast cells resemble lung mast cells in their ability to release histamine. They will help in studying the functional properties of human mast cells and may contribute to clarifying the pathophysiology of human allergic diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735874

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  5 in total

1.  Interferon-gamma promotes the survival and Fc epsilon RI-mediated histamine release in cultured human mast cells.

Authors:  M Yanagida; H Fukamachi; M Takei; T Hagiwara; H Uzumaki; T Tokiwa; H Saito; Y Iikura; T Nakahata
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

2.  Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells.

Authors:  Duraisamy Kempuraj; Bhuvaneshwari Madhappan; Spyridon Christodoulou; William Boucher; Jing Cao; Nikoletta Papadopoulou; Curtis L Cetrulo; Theoharis C Theoharides
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

3.  Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6.

Authors:  Fay Hollins; Davinder Kaur; Weidong Yang; Glenn Cruse; Ruth Saunders; Amanda Sutcliffe; Patrick Berger; Akihiko Ito; Christopher E Brightling; Peter Bradding
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

4.  Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans.

Authors:  Zuyi Weng; Bodi Zhang; Shahrzad Asadi; Nikolaos Sismanopoulos; Alan Butcher; Xueyan Fu; Alexandra Katsarou-Katsari; Christina Antoniou; Theoharis C Theoharides
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

5.  IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.

Authors:  U Westin; E Lundberg; K Ohlsson
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.